Trulieve Cannabis Corp.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(in thousands)
| Nine Months EndedSeptember 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities | ||
| Net loss | $(403,005) | $(78,654) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Depreciation and amortization | 73,173 | 88,211 |
| Depreciation included in cost of goods sold | 39,672 | 41,526 |
| Loss on Deconsolidation Transaction | 403,333 | — |
| Equity in net loss of Harvest | 9,721 | — |
| Impairment and disposal of long-lived assets, net of recoveries | 1,688 | 2,472 |
| Gain from disposal of discontinued operations | (7) | — |
| Share-based compensation | 16,950 | 16,490 |
| Deferred income taxes | (20,916) | (14,666) |
| Other non-cash changes | 9,802 | 15,953 |
| Changes in operating assets and liabilities: | ||
| Inventories | 2,042 | (11,920) |
| Accounts receivable | (2,140) | (3,396) |
| Other assets | (24,233) | 3,349 |
| Accounts payable and accrued liabilities | 1,417 | (11,557) |
| Income tax receivable / payable | 766 | 2,637 |
| Uncertain tax position liabilities | 88,136 | 171,094 |
| Other liabilities | (13,131) | (13,665) |
| Proceeds received from insurance for operating expenses | — | 5,731 |
| Net cash provided by operating activities | 183,268 | 213,605 |
| Cash flows from investing activities | ||
| Capital expenditures | (63,517) | (53,408) |
| Maturities of short-term investments | — | 60,000 |
| Cash disposed in Deconsolidation Transaction | (58,395) | — |
| Purchase of intangible assets | (40,000) | — |
| Other proceeds | 5,125 | 12,920 |
| Other purchases and payments | — | (117) |
| Net cash (used in) provided by investing activities | (156,787) | 19,395 |
| Cash flows from financing activities | ||
| Proceeds from long-term borrowings | 60,742 | — |
| Payments on long-term borrowings | (4,654) | (7,468) |
| Payments for debt issuance costs | (1,288) | — |
| Other payments and distributions | (7,834) | (7,146) |
| Payments for taxes related to net share settlement of equity awards | (2,663) | (491) |
| Other proceeds | 368 | — |
| Net cash provided by (used in) financing activities | 44,671 | (15,105) |
| Net increase in cash and cash equivalents, and restricted cash | 71,152 | 217,895 |
| Cash, cash equivalents, and restricted cash, beginning of period | 255,535 | 239,710 |
| Cash, cash equivalents, and restricted cash, end of period | $326,687 | $457,605 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)(Continued)
(in thousands)
| Nine Months EndedSeptember 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Supplemental disclosure of cash flow information | ||
| Cash paid during the period for | ||
| Interest | $34,267 | $41,591 |
| Income taxes paid, net of refunds of $3 and $2,034, respectively | 2,252 | 1,597 |
| Noncash investing and financing activities | ||
| ASC 842 lease additions - operating and finance leases | $29,698 | $14,595 |
| Purchases of property and equipment in accounts payable and accrued liabilities | 5,312 | 3,718 |
| Operating license intangible placed into service, transfer from other assets | — | 6,500 |
| Purchases of intangible assets in accounts payable and accrued liabilities | 400 | — |
| Write-off of allowance for credit losses on notes receivable due to uncollectibility | — | 4,961 |
The condensed consolidated statements of cash flows include continuing operations and discontinued operations for the periods presented.
The following table summarizes the cash, cash equivalent, and restricted cash balances for each of the periods presented:
| September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Beginning of period: | ||
| Cash and cash equivalents (1) | $255,535 | $238,803 |
| Restricted cash | — | 907 |
| Cash, cash equivalents, and restricted cash | $255,535 | $239,710 |
| End of period: | ||
| Cash and cash equivalents (1) | $326,687 | $449,198 |
| Restricted cash - current | — | 907 |
| Restricted cash | — | 7,500 |
| Cash, cash equivalents, and restricted cash | $326,687 | $457,605 |
(1) Excludes discontinued operations, which did not generate cash flows in any period presented.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.